REGENXBIO Inc. (RGNX) has seen some recent action in the stock market and its shares finished trading at $29.32 yesterday. Investors are starting to take interest of RGNX as the shares traded as high as $29.69 and as low as $27.59 in the prior trading session.
REGENXBIO Inc. (RGNX) average trading volume is 347.42K. However, in the prior trading session REGENXBIO Inc. (RGNX) exchanged 300,841 shares. The 1st downside support level on RGNX is $28.47 and the 1st resistance level on RGNX is $44.31. RGNX 50day moving average is $28.33 and RGNX 200 day moving average is $34.18.
REGENXBIO Inc. (RGNX) current performance has been indicated by the recent movement in RGNX shares. RGNX has performed 6.54% over the past 4 weeks, RGNX has performed -11.42% over the past 3 months and RGNX has shown -15.11% over the past year. REGENXBIO Inc. (RGNX) has a 1 year range of $20.03 to $54.97. REGENXBIO Inc. (RGNX) is trading 46.38% from its 1 year low and -46.66% from its 1 year high. REGENXBIO Inc. (RGNX) is displaying a 13.65% short float displaying the amount short in the float.
RGNX has 37.26M shares outstanding and 31.83M shares in the float. REGENXBIO Inc. (RGNX) at this time has a market cap of $1.08B and income of -134.80M. The EPS next quarter for RGNX is -1.01 and projected EPS next year is 21.80%. The market cap of REGENXBIO Inc. (RGNX) at $1.08B represents how many Investors own shares of RGNX and is calculated off the last price ($29.32) of RGNX and the amount of shares outstanding (37.26M) with REGENXBIO Inc. (RGNX).
REGENXBIO Inc. (RGNX) has total cash (mrq) of 269.19M, total cash per share (mrq) of 7.21, total debt of RGNX remains at 10.1M and total debt/equity (mrq) is 2.54. . REGENXBIO Inc. (RGNX) operating cash flow (ttm) is -111.73M, RGNX leveraged free cash flow (ttm) is -97.77M.
RGNX is trading 3.60% above (bullish) its SMA20, 2.29% above (bullish) its SMA50 and -18.61% below (bearish) its SMA200.